Collegium Pharmaceutical Inc (NASDAQ: COLL) is 27.39% higher on its value in year-to-date trading and has touched a low of $20.95 and a high of $40.95 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The COLL stock was last observed hovering at around $39.70 in the last trading session, with the day’s loss setting it -0.49%.
Currently trading at $39.21, the stock is 3.76% and 6.50% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.74 million and changing -1.23% at the moment leaves the stock 12.47% off its SMA200. COLL registered 72.28% gain for a year compared to 6-month loss of -0.61%. The firm has a 50-day simple moving average (SMA 50) of $36.9306 and a 200-day simple moving average (SMA200) of $34.91205.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 4.78% gain in the last 1 month and extending the period to 3 months gives it a 21.17%, and is 4.84% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.90% over the week and 3.56% over the month.
Collegium Pharmaceutical Inc (COLL) has around 197 employees, a market worth around $1.26B and $576.65M in sales. Current P/E ratio is 15.20 and Fwd P/E is 5.71. Profit margin for the company is 17.32%. Distance from 52-week low is 87.16% and -4.25% from its 52-week high. The company has generated returns on investments over the last 12 months (16.88%).
The EPS is expected to grow by 15.50% this year
324.0 institutions hold shares in Collegium Pharmaceutical Inc (COLL), with institutional investors hold 127.49% of the company’s shares. The shares outstanding are 31.87M, and float is at 31.21M with Short Float at 20.35%. Institutions hold 125.81% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 5.79 million shares valued at $186.55 million. The investor’s holdings represent 17.9214 of the COLL Shares outstanding. As of 2024-06-30, the second largest holder is PACER ADVISORS, INC. with 3.41 million shares valued at $109.75 million to account for 10.5435 of the shares outstanding. The other top investors are EVENTIDE ASSET MANAGEMENT, LLC which holds 2.63 million shares representing 8.1501 and valued at over $84.84 million, while VANGUARD GROUP INC holds 7.3343 of the shares totaling 2.37 million with a market value of $76.34 million.
Collegium Pharmaceutical Inc (COLL) Insider Activity
The most recent transaction is an insider sale by Smith Thomas B, the company’s EVP and Chief Medical Officer. SEC filings show that Smith Thomas B sold 9,593 shares of the company’s common stock on Sep 13 ’24 at a price of $36.62 per share for a total of $0.35 million. Following the sale, the insider now owns 53816.0 shares.
Still, SEC filings show that on Sep 13 ’24, Smith Thomas B (Officer) Proposed Sale 9,220 shares at an average price of $36.61 for $0.34 million. The insider now directly holds shares of Collegium Pharmaceutical Inc (COLL).
